Company Deep Dive
Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.
VEEV
Strong BuyPremium GrowerVeeva Systems Inc. · Healthcare · United States · $44.8B · Avg Vol: $492M/d
COMPANY DESCRIPTION
Veeva Systems Inc. is a leading provider of cloud-based software for the global life sciences industry, offering solutions for CRM, content management, clinical trials, and quality management. The company dominates the life sciences cloud software market with a comprehensive suite of purpose-built applications, creating high switching costs for pharmaceutical and biotech companies. Veeva is a critical technology partner for the life sciences industry, driving digital transformation and compliance for drug development and commercialization.
FINANCIAL SUMMARY (USD)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.2B | 2.4B | 2.7B | 3.2B | 14.0% | 3.5B | 3.7B | 4.1B | 13.8% |
| EPS | 3.14 | 3.27 | 4.41 | 5.55 | 20.9% | 6.11 | 6.33 | 7.02 | 12.4% |
| Shares | 158.2M | 161.3M | 162.6M | 163.8M | +3.5% | 161.9M | — | — | — |
| Debt | 61.0M | 55.8M | 75.8M | 95.9M | 16.3% | 151.7M | — | — | — |
| Equity | 3.7B | 4.6B | 5.8B | 7.2B | 24.7% | — | — | — | — |
| Op CF | 780.5M | 911.3M | 1.1B | 1.4B | 21.9% | 1.7B | — | — | — |
| Inv CF | -1.0B | -1.1B | -700.1M | -1.1B | — | — | — | — | — |
| Fin CF | -19.4M | -16.2M | 26.1M | -9.3M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of VEEV are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| VEEV | Veeva Systems Inc.(you) | $44.8B | 82 | Strong Buy |
| BTSG | BrightSpring Health Services, Inc. | $11.7B | 84 | Strong Buy |
| HQY | HealthEquity, Inc. | $8.0B | 82 | Strong Buy |
| HNGE | Hinge Health, Inc. | $7.0B | 84 | Strong Buy |
| TXG | 10x Genomics, Inc. | $8.0B | 60 | Hold |
| WAY | Waystar Holding Corp. | $5.0B | 62 | Hold |
| DOCS | Doximity, Inc. | $4.8B | 61 | Hold |
| GDRX | GoodRx Holdings, Inc. | $1.2B | 77 | Buy |
| TEM | Tempus AI, Inc. | $11.6B | 31 | Sell |
| OMCL | Omnicell, Inc. | $1.5B | 66 | Buy |
Peer medians: ROE -30.8% · P/E 26.9x · Gross margin 58.1%